| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| - - | HOLD | 0 @ 0 | 0 | |
| ABCL - Abcellera Biologics Inc | HOLD | 0 @ 2.4 | 0 | |
| ABSI - Absci Corp | HOLD | 0 @ USD 2.90001 | USD 0 | The current share valuation price of ABSI based on adjusted close was USD 2.90001. The average price that ABSI shares were previous bought at was USD 3.91137. The current market price is -25.9% lower than average price they were purchased at. The value of the holding in ABSI has fallen by USD 12,479 compared to the previous valuation of Absci Corp |
| ABUS - Arbutus Biopharma Corp | HOLD | 0 @ 3.32 | 0 | |
| ACAD - ACADIA Pharmaceuticals Inc | HOLD | 0 @ 16.78 | 0 | |
| ACIU - AC Immune Ltd | HOLD | 0 @ 2.29999 | 0 | |
| ACLX - Arcellx Inc | HOLD | 0 @ 71.58 | 0 | |
| ACRV - Acrivon Therapeutics, Inc. Common Stock | HOLD | 0 @ USD 5.07001 | USD 0 | The current share valuation price of ACRV based on adjusted close was USD 5.07001. The average price that ACRV shares were previous bought at was USD 5.40334. The current market price is -6.2% lower than average price they were purchased at. The value of the holding in ACRV has fallen by USD 3,999 compared to the previous valuation of Acrivon Therapeutics, Inc. Common Stock |
| ADMA - ADMA Biologics Inc | HOLD | 0 @ 17.91 | 0 | |
| ADPT - Adaptive Biotechnologies Corp | HOLD | 0 @ 7.17 | 0 | |
| AGIO - Agios Pharm | HOLD | 0 @ 31.07 | 0 | |
| AKRO - Akero Therapeutics Inc | HOLD | 0 @ 44.86 | 0 | |
| ALEC - Alector Inc | HOLD | 0 @ 1.43 | 0 | |
| ALKS - Alkermes Plc | HOLD | 0 @ 33.62 | 0 | |
| ALLO - Allogene Therapeutics Inc | HOLD | 0 @ 1.89 | 0 | |
| ALMS - Alumis Inc. Common Stock | HOLD | 0 @ USD 4.59 | USD 0 | The current share valuation price of ALMS based on adjusted close was USD 4.59. The average price that ALMS shares were previous bought at was USD 6.215. The current market price is -26.1% lower than average price they were purchased at. The value of the holding in ALMS has fallen by USD 9,564 compared to the previous valuation of Alumis Inc. Common Stock |
| ALNY - Alnylam Pharmaceuticals Inc | HOLD | 0 @ 241.75 | 0 | |
| ALT - Altitude Group Plc | HOLD | 0 @ 5.19999 | 0 | |
| ALVO - Alvotech | HOLD | 0 @ USD 11.18 | USD 0 | The current share valuation price of ALVO based on adjusted close was USD 11.18. The average price that ALVO shares were previous bought at was USD 12.8525. The current market price is -13.0% lower than average price they were purchased at. The value of the holding in ALVO has fallen by USD 25,019 compared to the previous valuation of Alvotech |
| AMGN - Amgen Inc | HOLD | 0 @ 312.64 | 0 | |
| AMLX - Amylyx Pharmaceuticals Inc | HOLD | 0 @ 3.67001 | 0 | |
| AMPH - Amphastar P | HOLD | 0 @ 26.24 | 0 | |
| AMRN - Amarin Corporation PLC | HOLD | 0 @ 0.409999 | 0 | |
| AMRX - Amneal Pharmaceuticals, Inc. Class A Common Stock | HOLD | 0 @ 8.79 | 0 | |
| ANAB - AnaptysBio Inc | HOLD | 0 @ 16.84 | 0 | |
| ANIP - ANI Pharmaceuticals Inc | HOLD | 0 @ 61.455 | 0 | |
| ANNX - Annexon Inc | HOLD | 0 @ USD 2.53 | USD 0 | The current share valuation price of ANNX based on adjusted close was USD 2.53. The average price that ANNX shares were previous bought at was USD 3.4903. The current market price is -27.5% lower than average price they were purchased at. The value of the holding in ANNX has fallen by USD 6,847 compared to the previous valuation of Annexon Inc |
| APGE - Apogee Therapeutics, Inc. Common Stock | HOLD | 0 @ 38.33 | 0 | |
| APLS - Apellis Pharmaceuticals Inc | HOLD | 0 @ 24.37 | 0 | |
| APLT - Applied Therapeutics Inc | HOLD | 0 @ USD 0.499696 | USD 0 | The current share valuation price of APLT based on adjusted close was USD 0.499696. The average price that APLT shares were previous bought at was USD 0.598788. The current market price is -16.5% lower than average price they were purchased at. The value of the holding in APLT has fallen by USD 1,305 compared to the previous valuation of Applied Therapeutics Inc |
| AQST - Aquestive Therapeutics Inc | HOLD | 0 @ USD 2.72 | USD 0 | The current share valuation price of AQST based on adjusted close was USD 2.72. The average price that AQST shares were previous bought at was USD 3.11305. The current market price is -12.6% lower than average price they were purchased at. The value of the holding in AQST has fallen by USD 9,910 compared to the previous valuation of Aquestive Therapeutics Inc |
| ARCT - Arcturus Therapeutics Holdings Inc | HOLD | 0 @ 13.9 | 0 | |
| ARDX - Ardelyx Inc | HOLD | 0 @ 5.42 | 0 | |
| ARGX - argenx NV ADR | HOLD | 0 @ 581.21 | 0 | |
| ARQT - Arcutis Biotherapeutics Inc | HOLD | 0 @ 14.81 | 0 | |
| ARTV - Artiva Biotherapeutics, Inc. Common Stock | HOLD | 0 @ USD 5.59997 | USD 0 | The current share valuation price of ARTV based on adjusted close was USD 5.59997. The average price that ARTV shares were previous bought at was USD 8.26974. The current market price is -32.3% lower than average price they were purchased at. The value of the holding in ARTV has fallen by USD 7,797 compared to the previous valuation of Artiva Biotherapeutics, Inc. Common Stock |
| ARVN - Arvinas Inc | HOLD | 0 @ 8.55001 | 0 | |
| ARWR - Arrowhead Pharmaceuticals Inc | HOLD | 0 @ 15.07 | 0 | |
| ASND - Ascendis Pharma AS | HOLD | 0 @ 152.31 | 0 | |
| ATXS - Astria Therapeutics Inc | HOLD | 0 @ USD 6.63999 | USD 0 | The current share valuation price of ATXS based on adjusted close was USD 6.63999. The average price that ATXS shares were previous bought at was USD 7.17722. The current market price is -7.5% lower than average price they were purchased at. The value of the holding in ATXS has fallen by USD 13,940 compared to the previous valuation of Astria Therapeutics Inc |
| AUPH - Aurinia Pharmaceuticals Inc | HOLD | 0 @ 8.11001 | 0 | |
| AURA - Aura Energy Ltd | HOLD | 0 @ USD 7.26001 | USD 0 | The current share valuation price of AURA based on adjusted close was USD 7.26001. The average price that AURA shares were previous bought at was USD 7.72111. The current market price is -6.0% lower than average price they were purchased at. The value of the holding in AURA has fallen by USD 5,674 compared to the previous valuation of Aura Energy Ltd |
| AUTL - Autolus Therapeutics Ltd | HOLD | 0 @ 1.89 | 0 | |
| AVBP - ArriVent BioPharma, Inc. Common Stock | HOLD | 0 @ USD 21.75 | USD 0 | The current share valuation price of AVBP based on adjusted close was USD 21.75. The average price that AVBP shares were previous bought at was USD 25.6142. The current market price is -15.1% lower than average price they were purchased at. The value of the holding in AVBP has fallen by USD 11,640 compared to the previous valuation of ArriVent BioPharma, Inc. Common Stock |
| AVDL - Avadel Pharmaceuticals PLC | HOLD | 0 @ 8.39001 | 0 | |
| AVIR - Atea Pharmaceuticals Inc | HOLD | 0 @ 3.06 | 0 | |
| AVXL - Anavex Life Sciences Corp | HOLD | 0 @ 9 | 0 | |
| AXSM - Axsome Therapeutics Inc | HOLD | 0 @ 121.65 | 0 | |
| AZN - AstraZeneca PLC | HOLD | 0 @ 76.51 | 0 | |
| BBIO - BridgeBio Pharma Inc | HOLD | 0 @ 32.31 | 0 | |
| BCRX - BioCryst Pharmaceuticals Inc | HOLD | 0 @ 7.54 | 0 | |
| BCYC - Bicycle Therapeutics Ltd | HOLD | 0 @ 9.62999 | 0 | |
| BEAM - Beam Therapeutics Inc | HOLD | 0 @ 25.06 | 0 | |
| BIIB - Biogen Inc | HOLD | 0 @ 139.98 | 0 | |
| BMEA - Biomea Fusion Inc | HOLD | 0 @ 2.65999 | 0 | |
| BMRN - Biomarin Pharmaceutical Inc | HOLD | 0 @ 70.6 | 0 | |
| BNTX - BioNTech SE | HOLD | 0 @ 97.465 | 0 | |
| BPMC - Blueprint Medicines Corp | HOLD | 0 @ 89.84 | 0 | |
| CCCC - C4 Therapeutics Inc | HOLD | 0 @ USD 2.01999 | USD 0 | The current share valuation price of CCCC based on adjusted close was USD 2.01999. The average price that CCCC shares were previous bought at was USD 3.48667. The current market price is -42.1% lower than average price they were purchased at. The value of the holding in CCCC has fallen by USD 5,928 compared to the previous valuation of C4 Therapeutics Inc |
| CDXS - Codexis Inc | HOLD | 0 @ USD 2.53 | USD 0 | The current share valuation price of CDXS based on adjusted close was USD 2.53. The average price that CDXS shares were previous bought at was USD 4.48222. The current market price is -43.6% lower than average price they were purchased at. The value of the holding in CDXS has fallen by USD 9,247 compared to the previous valuation of Codexis Inc |
| CGEM - Cullinan Oncology LLC | HOLD | 0 @ 8.91998 | 0 | |
| CGON - CG Oncology, Inc. Common stock | HOLD | 0 @ 25.95 | 0 | |
| CLYM - Climb Bio Inc | HOLD | 0 @ USD 1.33001 | USD 0 | The current share valuation price of CLYM based on adjusted close was USD 1.33001. The average price that CLYM shares were previous bought at was USD 1.72777. The current market price is -23.0% lower than average price they were purchased at. The value of the holding in CLYM has increased by USD 2,657 compared to the previous valuation of Climb Bio Inc however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| CMPS - Compass Pathways Plc | HOLD | 0 @ USD 3.49 | USD 0 | The current share valuation price of CMPS based on adjusted close was USD 3.49. The average price that CMPS shares were previous bought at was USD 3.82453. The current market price is -8.7% lower than average price they were purchased at. The value of the holding in CMPS has fallen by USD 6,026 compared to the previous valuation of Compass Pathways Plc |
| CNTA - Centessa Pharmaceuticals PLC ADR | HOLD | 0 @ 16.87 | 0 | |
| COGT - Cogent Biosciences Inc | HOLD | 0 @ 7.29 | 0 | |
| COLL - Collegium Pharmaceutical Inc | HOLD | 0 @ 29.1 | 0 | |
| CRGX - CARGO Therapeutics, Inc. Common Stock | HOLD | 0 @ 4.13001 | 0 | |
| CRMD - CorMedix Inc | HOLD | 0 @ USD 10.38 | USD 0 | The current share valuation price of CRMD based on adjusted close was USD 10.38. The average price that CRMD shares were previous bought at was USD 11.2168. The current market price is -7.5% lower than average price they were purchased at. The value of the holding in CRMD has fallen by USD 17,671 compared to the previous valuation of CorMedix Inc |
| CRNX - Crinetics Pharmaceuticals Inc | HOLD | 0 @ 35.04 | 0 | |
| CRSP - Crispr Therapeutics AG | HOLD | 0 @ 41.99 | 0 | |
| CRVS - Corvus Pharmaceuticals Inc | HOLD | 0 @ USD 4.5 | USD 0 | The current share valuation price of CRVS based on adjusted close was USD 4.5. The average price that CRVS shares were previous bought at was USD 4.80354. The current market price is -6.3% lower than average price they were purchased at. The value of the holding in CRVS has fallen by USD 4,126 compared to the previous valuation of Corvus Pharmaceuticals Inc |
| CSTL - Castle Biosciences Inc | HOLD | 0 @ 18.76 | 0 | |
| CVAC - CureVac NV | HOLD | 0 @ 3.03 | 0 | |
| CYTK - Cytokinetics Inc | HOLD | 0 @ 44.4 | 0 | |
| DAWN - Day One Biopharmaceuticals Inc | HOLD | 0 @ 8.7 | 0 | |
| DNLI - Denali Therapeutics Inc | HOLD | 0 @ 14.89 | 0 | |
| DSGN - Design Therapeutics Inc | HOLD | 0 @ USD 4.71999 | USD 0 | The current share valuation price of DSGN based on adjusted close was USD 4.71999. The average price that DSGN shares were previous bought at was USD 4.38186. The current market price is 7.7% higher than average price they were purchased at. The value of the holding in DSGN has fallen by USD 6,713 compared to the previous valuation of Design Therapeutics Inc |
| DVAX - Dynavax Technologies Corporation | HOLD | 0 @ 13.69 | 0 | |
| DYN - Dyne Therapeutics Inc | HOLD | 0 @ 11.88 | 0 | |
| DYN - DYNAGREEN EN.PR.GR.H YC 1 | HOLD | 0 @ 11.88 | 0 | |
| EDIT - Editas Medicine Inc | HOLD | 0 @ 1.37001 | 0 | |
| ELVN - Enliven Therapeutics Inc. | HOLD | 0 @ 20.29 | 0 | |
| ENTA - Enanta Pharmaceuticals Inc | HOLD | 0 @ USD 6.83 | USD 0 | The current share valuation price of ENTA based on adjusted close was USD 6.83. The average price that ENTA shares were previous bought at was USD 6.00555. The current market price is 13.7% higher than average price they were purchased at. The value of the holding in ENTA has fallen by USD 4,605 compared to the previous valuation of Enanta Pharmaceuticals Inc |
| EOLS - Evolus Inc | HOLD | 0 @ 12.96 | 0 | |
| ERAS - Erasca Inc | HOLD | 0 @ 1.47 | 0 | |
| ESPR - Esperion Therapeutics Inc | HOLD | 0 @ USD 1.50001 | USD 0 | The current share valuation price of ESPR based on adjusted close was USD 1.50001. The average price that ESPR shares were previous bought at was USD 1.99879. The current market price is -25.0% lower than average price they were purchased at. The value of the holding in ESPR has fallen by USD 1,946 compared to the previous valuation of Esperion Therapeutics Inc |
| ETNB - 89bio Inc | HOLD | 0 @ 8.18001 | 0 | |
| EWTX - Edgewise Therapeutics Inc | HOLD | 0 @ 25.28 | 0 | |
| EXEL - Exelixis Inc | HOLD | 0 @ 36.8 | 0 | |
| EYPT - Eyepoint Pharmaceuticals Inc | HOLD | 0 @ 6.83 | 0 | |
| FATE - Fate Therapeutics Inc | HOLD | 0 @ 0.9435 | 0 | |
| FDMT - 4D Molecular Therapeutics Inc | HOLD | 0 @ 4.27999 | 0 | |
| FHTX - Foghorn Therapeutics Inc | HOLD | 0 @ USD 4.47999 | USD 0 | The current share valuation price of FHTX based on adjusted close was USD 4.47999. The average price that FHTX shares were previous bought at was USD 4.98445. The current market price is -10.1% lower than average price they were purchased at. The value of the holding in FHTX has fallen by USD 2,747 compared to the previous valuation of Foghorn Therapeutics Inc |
| FOLD - Amicus Therapeutics Inc | HOLD | 0 @ 8.81 | 0 | |
| FTRE - Fortrea Holdings Inc. | HOLD | 0 @ 9.58 | 0 | |
| GERN - Geron Corporation | HOLD | 0 @ 1.67 | 0 | |
| GH - Guardant Health Inc | HOLD | 0 @ 40.64 | 0 | |
| GILD - Guild Esports Plc | HOLD | 0 @ 113.35 | 0 | |
| GLPG - Galapagos NV ADR | HOLD | 0 @ 25.99 | 0 | |
| GLPG - Galapagos N.V. | HOLD | 0 @ 25.99 | 0 | |
| GLUE - Monte Rosa Therapeutics Inc | HOLD | 0 @ USD 6.21 | USD 0 | The current share valuation price of GLUE based on adjusted close was USD 6.21. The average price that GLUE shares were previous bought at was USD 6.00722. The current market price is 3.4% higher than average price they were purchased at. The value of the holding in GLUE has fallen by USD 13,050 compared to the previous valuation of Monte Rosa Therapeutics Inc |
| GMAB - Genmab AS | HOLD | 0 @ 19.96 | 0 | |
| GPCR - Structure Therapeutics Inc. American Depositary Shares | HOLD | 0 @ 20.4 | 0 | |
| GRAL - GRAIL, LLC | HOLD | 0 @ 26.92 | 0 | |
| GRFS - Grifols SA ADR | HOLD | 0 @ 7.72001 | 0 | |
| HALO - Halozyme Therapeutics Inc | HOLD | 0 @ 61.06 | 0 | |
| HCM - HUTCHMED China Ltd | HOLD | 0 @ 15.37 | 0 | |
| HCM - Hitachi Construction Machinery Co. Ltd | HOLD | 0 @ 15.37 | 0 | |
| HRMY - Harmony Biosciences Holdings | HOLD | 0 @ 32.72 | 0 | |
| HROW - Harrow Health Inc | HOLD | 0 @ 22.24 | 0 | |
| HUMA - Humacyte Inc | HOLD | 0 @ 2.77 | 0 | |
| IBRX - Immunitybio Inc | HOLD | 0 @ 2.9 | 0 | |
| IDYA - Ideaya Biosciences Inc | HOLD | 0 @ 18.96 | 0 | |
| IGMS - IGM Biosciences Inc | HOLD | 0 @ USD 1.28998 | USD 0 | The current share valuation price of IGMS based on adjusted close was USD 1.28998. The average price that IGMS shares were previous bought at was USD 1.53723. The current market price is -16.1% lower than average price they were purchased at. The value of the holding in IGMS has fallen by USD 1,683 compared to the previous valuation of IGM Biosciences Inc |
| ILMN - Illumina Inc | HOLD | 0 @ 84.05 | 0 | |
| IMCR - Immunocore Holdings Ltd | HOLD | 0 @ 28.27 | 0 | |
| IMVT - Immunovant Inc | HOLD | 0 @ 18.79 | 0 | |
| INBX - Inhibrx Inc | HOLD | 0 @ USD 14.15 | USD 0 | The current share valuation price of INBX based on adjusted close was USD 14.15. The average price that INBX shares were previous bought at was USD 14.0203. The current market price is 0.9% higher than average price they were purchased at. The value of the holding in INBX has fallen by USD 3,720 compared to the previous valuation of Inhibrx Inc |
| INCY - Incyte Corporation | HOLD | 0 @ 67.71 | 0 | |
| INDV - Indivior PLC | HOLD | 0 @ USD 9.59 | USD 0 | The current share valuation price of INDV based on adjusted close was USD 9.59. The average price that INDV shares were previous bought at was USD 10.5604. The current market price is -9.2% lower than average price they were purchased at. The value of the holding in INDV has fallen by USD 11,440 compared to the previous valuation of Indivior PLC |
| INSM - Insmed Inc | HOLD | 0 @ 75.07 | 0 | |
| INVA - Innoviva Inc | HOLD | 0 @ 17.39 | 0 | |
| INZY - Inozyme Pharma Inc | HOLD | 0 @ USD 0.999685 | USD 0 | The current share valuation price of INZY based on adjusted close was USD 0.999685. The average price that INZY shares were previous bought at was USD 1.32334. The current market price is -24.5% lower than average price they were purchased at. The value of the holding in INZY has fallen by USD 2,549 compared to the previous valuation of Inozyme Pharma Inc |
| IONS - Ionis Pharmaceuticals Inc | HOLD | 0 @ 32.9 | 0 | |
| IOVA - Iovance Biotherapeutics Inc | HOLD | 0 @ 3.52 | 0 | |
| IRON - Ironveld Plc | HOLD | 0 @ 52.41 | 0 | |
| IRWD - Ironwood Pharmaceuticals Inc | HOLD | 0 @ 1.51 | 0 | |
| ITCI - Intracellular Th | HOLD | 0 @ 131.36 | 0 | |
| ITOS - Iteos Therapeutics Inc | HOLD | 0 @ 7.19001 | 0 | |
| JANX - Janux Therapeutics Inc | HOLD | 0 @ 31.35 | 0 | |
| JAZZ - Jazz Pharmaceuticals PLC | HOLD | 0 @ 136.05 | 0 | |
| KALV - Kalvista Pharmaceuticals Inc | HOLD | 0 @ 12.25 | 0 | |
| KNSA - Kiniksa Pharmaceuticals Ltd | HOLD | 0 @ 22.16 | 0 | |
| KROS - Keros Therapeutics Inc | HOLD | 0 @ 11.47 | 0 | |
| KRYS - Krystal Biotech Inc | HOLD | 0 @ 177.37 | 0 | |
| KURA - Kura Oncology Inc | HOLD | 0 @ 7.28001 | 0 | |
| KYMR - Kymera Therapeutics Inc | HOLD | 0 @ 33.45 | 0 | |
| KYTX - Kyverna Therapeutics, Inc. Common Stock | HOLD | 0 @ USD 2.50002 | USD 0 | The current share valuation price of KYTX based on adjusted close was USD 2.50002. The average price that KYTX shares were previous bought at was USD 3.12964. The current market price is -20.1% lower than average price they were purchased at. The value of the holding in KYTX has fallen by USD 639 compared to the previous valuation of Kyverna Therapeutics, Inc. Common Stock |
| LEGN - Legend Biotech Corp | HOLD | 0 @ 38.05 | 0 | |
| LENZ - LENZ Therapeutics Inc | HOLD | 0 @ USD 24.75 | USD 0 | The current share valuation price of LENZ based on adjusted close was USD 24.75. The average price that LENZ shares were previous bought at was USD 23.5122. The current market price is 5.3% higher than average price they were purchased at. The value of the holding in LENZ has increased by USD 2,037 compared to the previous valuation of LENZ Therapeutics Inc however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| LGND - Ligand Pharmaceuticals Incorporated | HOLD | 0 @ 105.62 | 0 | |
| LRMR - Larimar Therapeutics Inc | HOLD | 0 @ USD 2.61 | USD 0 | The current share valuation price of LRMR based on adjusted close was USD 2.61. The average price that LRMR shares were previous bought at was USD 3.21667. The current market price is -18.9% lower than average price they were purchased at. The value of the holding in LRMR has fallen by USD 2,522 compared to the previous valuation of Larimar Therapeutics Inc |
| LXEO - Lexeo Therapeutics, Inc. Common Stock | HOLD | 0 @ USD 2.97 | USD 0 | The current share valuation price of LXEO based on adjusted close was USD 2.97. The average price that LXEO shares were previous bought at was USD 5.80876. The current market price is -48.9% lower than average price they were purchased at. The value of the holding in LXEO has increased by USD 980 compared to the previous valuation of Lexeo Therapeutics, Inc. Common Stock however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| LXRX - Lexicon Pharmaceuticals Inc | HOLD | 0 @ 0.357002 | 0 | |
| LYEL - Lyell Immunopharma Inc | HOLD | 0 @ 0.606298 | 0 | |
| MDGL - Madrigal Pharmaceuticals Inc | HOLD | 0 @ 323.02 | 0 | |
| MEDP - Medpace Holdings Inc | HOLD | 0 @ 317.93 | 0 | |
| MESO - Mesoblast Ltd | HOLD | 0 @ USD 13.28 | USD 0 | The current share valuation price of MESO based on adjusted close was USD 13.28. The average price that MESO shares were previous bought at was USD 17.4841. The current market price is -24.0% lower than average price they were purchased at. The value of the holding in MESO has fallen by USD 2,682 compared to the previous valuation of Mesoblast Ltd |
| MGNX - MacroGenics Inc | HOLD | 0 @ 2.19999 | 0 | |
| MGTX - MeiraGTx Holdings PLC | HOLD | 0 @ 8.25001 | 0 | |
| MIRM - Mirum Pharmaceuticals Inc | HOLD | 0 @ 44.56 | 0 | |
| MLYS - Mineralys Therapeutics, Inc. Common Stock | HOLD | 0 @ 13.5 | 0 | |
| MNKD - MannKind Corp | HOLD | 0 @ 5.15 | 0 | |
| MNMD - Mind Medicine Inc | HOLD | 0 @ 6.31 | 0 | |
| MRNA - Moderna Inc | HOLD | 0 @ 34.3 | 0 | |
| MRSN - Mersana Therapeutics Inc | HOLD | 0 @ 0.448098 | 0 | |
| MRUS - Merus BV | HOLD | 0 @ 47.64 | 0 | |
| MRVI - Maravai Lifesciences Holdings Inc | HOLD | 0 @ 2.42001 | 0 | |
| MXCT - MaxCyte Inc | HOLD | 0 @ 3.06001 | 0 | |
| NAMS - NewAmsterdam Pharma Company N.V. Ordinary Shares | HOLD | 0 @ USD 23.58 | USD 0 | The current share valuation price of NAMS based on adjusted close was USD 23.58. The average price that NAMS shares were previous bought at was USD 20.9737. The current market price is 12.4% higher than average price they were purchased at. The value of the holding in NAMS has increased by USD 10,030 compared to the previous valuation of NewAmsterdam Pharma Company N.V. Ordinary Shares however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| NBIX - Neurocrine Biosciences Inc | HOLD | 0 @ 108.99 | 0 | |
| NGNE - Neurogene Inc | HOLD | 0 @ USD 16.8 | USD 0 | The current share valuation price of NGNE based on adjusted close was USD 16.8. The average price that NGNE shares were previous bought at was USD 17.5822. The current market price is -4.4% lower than average price they were purchased at. The value of the holding in NGNE has fallen by USD 7,189 compared to the previous valuation of Neurogene Inc |
| NKTX - Nkarta Inc | HOLD | 0 @ USD 1.71999 | USD 0 | The current share valuation price of NKTX based on adjusted close was USD 1.71999. The average price that NKTX shares were previous bought at was USD 2.23056. The current market price is -22.9% lower than average price they were purchased at. The value of the holding in NKTX has fallen by USD 3,486 compared to the previous valuation of Nkarta Inc |
| NMRA - Neumora Therapeutics, Inc. Common Stock | HOLD | 0 @ USD 1.39999 | USD 0 | The current share valuation price of NMRA based on adjusted close was USD 1.39999. The average price that NMRA shares were previous bought at was USD 1.86921. The current market price is -25.1% lower than average price they were purchased at. The value of the holding in NMRA has increased by USD 1,596 compared to the previous valuation of Neumora Therapeutics, Inc. Common Stock however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| NRIX - Nurix Therapeutics Inc | HOLD | 0 @ 13.19 | 0 | |
| NTLA - Intellia Therapeutics Inc | HOLD | 0 @ 9.22001 | 0 | |
| NUVL - Nuvalent Inc | HOLD | 0 @ 74.48 | 0 | |
| NVAX - Novavax Inc | HOLD | 0 @ 8.17 | 0 | |
| NVAX - Hana Microelectronics Public Company Limited | HOLD | 0 @ 8.17 | 0 | |
| NVCR - Novocure Ltd | HOLD | 0 @ 20.06 | 0 | |
| OABI - OmniAb Inc. | HOLD | 0 @ 3.21 | 0 | |
| OCUL - Ocular Therapeutix Inc | HOLD | 0 @ 7.87999 | 0 | |
| OKUR - OKUR | HOLD | 0 @ 4.62002 | 0 | |
| OLMA - Olema Pharmaceuticals Inc | HOLD | 0 @ 4.36999 | 0 | |
| OMER - Omeros Corporation | HOLD | 0 @ USD 7.86001 | USD 0 | The current share valuation price of OMER based on adjusted close was USD 7.86001. The average price that OMER shares were previous bought at was USD 8.983. The current market price is -12.5% lower than average price they were purchased at. The value of the holding in OMER has fallen by USD 4,293 compared to the previous valuation of Omeros Corporation |
| ONC - Oncimmune Holdings plc | HOLD | 0 @ USD 254.57 | USD 0 | The current share valuation price of ONC based on adjusted close was USD 254.57. The average price that ONC shares were previous bought at was USD 220.319. The current market price is 15.5% higher than average price they were purchased at. The value of the holding in ONC has increased by USD 103,488 compared to the previous valuation of Oncimmune Holdings plc however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| ONC - TEMPUS AI INC CLASS A | HOLD | 0 @ USD 254.57 | USD 0 | The current share valuation price of ONC based on adjusted close was USD 254.57. The average price that ONC shares were previous bought at was USD 220.319. The current market price is 15.5% higher than average price they were purchased at. The value of the holding in ONC has increased by USD 103,488 compared to the previous valuation of TEMPUS AI INC CLASS A however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| ORIC - Oric Pharmaceuticals Inc | HOLD | 0 @ 7.70001 | 0 | |
| ORKA - Oruka Therapeutics, Inc. | HOLD | 0 @ USD 11.14 | USD 0 | The current share valuation price of ORKA based on adjusted close was USD 11.14. The average price that ORKA shares were previous bought at was USD 11.7054. The current market price is -4.8% lower than average price they were purchased at. The value of the holding in ORKA has fallen by USD 7,089 compared to the previous valuation of Oruka Therapeutics, Inc. |
| PACB - Pacific Biosciences of California | HOLD | 0 @ 1.2 | 0 | |
| PAHC - Phibro Animal Health Corporation | HOLD | 0 @ 20.49 | 0 | |
| PCRX - Pacira BioSciences, Inc. | HOLD | 0 @ 22.69 | 0 | |
| PCVX - Vaxcyte Inc | HOLD | 0 @ 73.02 | 0 | |
| PEPG - PepGen Ltd | HOLD | 0 @ USD 2.24998 | USD 0 | The current share valuation price of PEPG based on adjusted close was USD 2.24998. The average price that PEPG shares were previous bought at was USD 1.78167. The current market price is 26.3% higher than average price they were purchased at. The value of the holding in PEPG has fallen by USD 3,542 compared to the previous valuation of PepGen Ltd |
| PGEN - Precigen Inc | HOLD | 0 @ 1.74 | 0 | |
| PHAT - Phathom Pharmaceuticals Inc | HOLD | 0 @ 4.22001 | 0 | |
| PLRX - Pliant Therapeutics Inc | HOLD | 0 @ 1.52001 | 0 | |
| PRAX - Praxis Precision Medicines Inc | HOLD | 0 @ 37.29 | 0 | |
| PRME - Prime Medicine, Inc. Common Stock | HOLD | 0 @ 1.72 | 0 | |
| PRTA - Prothena Corporation plc | HOLD | 0 @ 14.07 | 0 | |
| PSNL - Personalis Inc | HOLD | 0 @ USD 3.57001 | USD 0 | The current share valuation price of PSNL based on adjusted close was USD 3.57001. The average price that PSNL shares were previous bought at was USD 4.77056. The current market price is -25.2% lower than average price they were purchased at. The value of the holding in PSNL has fallen by USD 8,723 compared to the previous valuation of Personalis Inc |
| PTCT - PTC Therapeutics Inc | HOLD | 0 @ 52.76 | 0 | |
| PTGX - Protagonist Therapeutics Inc | HOLD | 0 @ 54.9 | 0 | |
| PYXS - Pyxis Oncology Inc | HOLD | 0 @ USD 1.06999 | USD 0 | The current share valuation price of PYXS based on adjusted close was USD 1.06999. The average price that PYXS shares were previous bought at was USD 1.36333. The current market price is -21.5% lower than average price they were purchased at. The value of the holding in PYXS has fallen by USD 1,175 compared to the previous valuation of Pyxis Oncology Inc |
| QTTB - Q32 Bio Inc | HOLD | 0 @ USD 1.83998 | USD 0 | The current share valuation price of QTTB based on adjusted close was USD 1.83998. The average price that QTTB shares were previous bought at was USD 2.93553. The current market price is -37.3% lower than average price they were purchased at. The value of the holding in QTTB has fallen by USD 474 compared to the previous valuation of Q32 Bio Inc |
| QURE - Uniqure NV | HOLD | 0 @ 13.78 | 0 | |
| RAPP - Rapport Therapeutics, Inc. Common Stock | HOLD | 0 @ USD 10.02 | USD 0 | The current share valuation price of RAPP based on adjusted close was USD 10.02. The average price that RAPP shares were previous bought at was USD 13.9311. The current market price is -28.1% lower than average price they were purchased at. The value of the holding in RAPP has increased by USD 180 compared to the previous valuation of Rapport Therapeutics, Inc. Common Stock however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| RARE - Ultragenyx | HOLD | 0 @ 39.25 | 0 | |
| RARE - WISETFWTMRARETFP | HOLD | 0 @ 39.25 | 0 | |
| RCKT - Rocket Pharmaceuticals Inc | HOLD | 0 @ 8.5 | 0 | |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ 680.61 | 0 | |
| REPL - Replimune Group Inc | HOLD | 0 @ 11.86 | 0 | |
| RGNX - Regenxbio Inc | HOLD | 0 @ 6.55 | 0 | |
| RIGL - Rigel Pharmaceuticals Inc | HOLD | 0 @ USD 19.9101 | USD 0 | The current share valuation price of RIGL based on adjusted close was USD 19.9101. The average price that RIGL shares were previous bought at was USD 19.9894. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in RIGL has fallen by USD 4,520 compared to the previous valuation of Rigel Pharmaceuticals Inc |
| RLAY - Relay Therapeutics Inc | HOLD | 0 @ 3.41 | 0 | |
| RNA - Avidity Biosciences Inc | HOLD | 0 @ 32.13 | 0 | |
| RNAC - Cartesian Therapeutics Inc. | HOLD | 0 @ USD 16.61 | USD 0 | The current share valuation price of RNAC based on adjusted close was USD 16.61. The average price that RNAC shares were previous bought at was USD 18.9509. The current market price is -12.4% lower than average price they were purchased at. The value of the holding in RNAC has fallen by USD 10,920 compared to the previous valuation of Cartesian Therapeutics Inc. |
| ROIV - Roivant Sciences Ltd | HOLD | 0 @ 10.42 | 0 | |
| RPRX - Royalty Pharma Plc | HOLD | 0 @ 32.68 | 0 | |
| RVMD - Revolution Medicines Inc | HOLD | 0 @ 39.03 | 0 | |
| RXRX - Recursion Pharmaceuticals Inc | HOLD | 0 @ 5.94 | 0 | |
| RYTM - Rhythm Pharmaceuticals Inc | HOLD | 0 @ 50.24 | 0 | |
| SAGE - Sage Therapeutic | HOLD | 0 @ 7.85001 | 0 | |
| SANA - Sana Biotechnology Inc | HOLD | 0 @ 2.655 | 0 | |
| SCPH - Scpharmaceuticals Inc | HOLD | 0 @ USD 2.99001 | USD 0 | The current share valuation price of SCPH based on adjusted close was USD 2.99001. The average price that SCPH shares were previous bought at was USD 3.405. The current market price is -12.2% lower than average price they were purchased at. The value of the holding in SCPH has fallen by USD 741 compared to the previous valuation of Scpharmaceuticals Inc |
| SIGA - SIGA Technologies Inc | HOLD | 0 @ 5.45001 | 0 | |
| SLDB - Solid Biosciences LLC | HOLD | 0 @ USD 5.14502 | USD 0 | The current share valuation price of SLDB based on adjusted close was USD 5.14502. The average price that SLDB shares were previous bought at was USD 3.62278. The current market price is 42.0% higher than average price they were purchased at. The value of the holding in SLDB has fallen by USD 11,545 compared to the previous valuation of Solid Biosciences LLC |
| SLN - Silence Therapeutics PLC | HOLD | 0 @ USD 4.05998 | USD 0 | The current share valuation price of SLN based on adjusted close was USD 4.05998. The average price that SLN shares were previous bought at was USD 4.67944. The current market price is -13.2% lower than average price they were purchased at. The value of the holding in SLN has fallen by USD 4,410 compared to the previous valuation of Silence Therapeutics PLC |
| SLRN - ACELYRIN, INC. Common Stock | HOLD | 0 @ 2.69001 | 0 | |
| SMMT - Summit Therapeutics PLC | HOLD | 0 @ 19.19 | 0 | |
| SNDX - Syndax Pharmaceuticals Inc | HOLD | 0 @ 13.1 | 0 | |
| SNY - Sanofi ADR | HOLD | 0 @ 57.75 | 0 | |
| SPRY - Silverback Therapeutics Inc | HOLD | 0 @ 11.95 | 0 | |
| SRPT - Sarepta Therapeutics Inc | HOLD | 0 @ 98.37 | 0 | |
| SRRK - Scholar Rock Holding Corp | HOLD | 0 @ 34.55 | 0 | |
| STOK - Stoke Therapeutics Inc | HOLD | 0 @ 8.11001 | 0 | |
| STRO - Sutro Biopharma | HOLD | 0 @ 1.25001 | 0 | |
| SUPN - Supernus Pharmaceuticals Inc | HOLD | 0 @ 31.17 | 0 | |
| SVRA - Savara Inc | HOLD | 0 @ 2.76 | 0 | |
| SWTX - SpringWorks Therapeutics Inc | HOLD | 0 @ 49.77 | 0 | |
| SYRE - Spyre Therapeutics Inc. | HOLD | 0 @ 18.03 | 0 | |
| TARS - Tarsus Pharmaceuticals Inc | HOLD | 0 @ 46.47 | 0 | |
| TBPH - Theravance Biopharma Inc | HOLD | 0 @ 9.28001 | 0 | |
| TCRX - Tscan Therapeutics Inc | HOLD | 0 @ USD 1.79 | USD 0 | The current share valuation price of TCRX based on adjusted close was USD 1.79. The average price that TCRX shares were previous bought at was USD 2.22722. The current market price is -19.6% lower than average price they were purchased at. The value of the holding in TCRX has fallen by USD 243 compared to the previous valuation of Tscan Therapeutics Inc |
| TECX - Tectonic Therapeutic, Inc. | HOLD | 0 @ USD 23.51 | USD 0 | The current share valuation price of TECX based on adjusted close was USD 23.51. The average price that TECX shares were previous bought at was USD 35.9025. The current market price is -34.5% lower than average price they were purchased at. The value of the holding in TECX has fallen by USD 8,078 compared to the previous valuation of Tectonic Therapeutic, Inc. |
| TEM - Templeton Emerging Markets Investment Trust TEMIT | HOLD | 0 @ USD 42.165 | USD 0 | The current share valuation price of TEM based on adjusted close was USD 42.165. The average price that TEM shares were previous bought at was USD 55.9872. The current market price is -24.7% lower than average price they were purchased at. The value of the holding in TEM has fallen by USD 250,796 compared to the previous valuation of Templeton Emerging Markets Investment Trust TEMIT |
| TEM - TEMPUS AI INC CLASS A | HOLD | 0 @ USD 42.165 | USD 0 | The current share valuation price of TEM based on adjusted close was USD 42.165. The average price that TEM shares were previous bought at was USD 55.9872. The current market price is -24.7% lower than average price they were purchased at. The value of the holding in TEM has fallen by USD 250,796 compared to the previous valuation of TEMPUS AI INC CLASS A |
| TERN - Tern Plc | HOLD | 0 @ 3.45 | 0 | |
| THRD - Third Harmonic Bio Inc. | HOLD | 0 @ 3.45001 | 0 | |
| TKNO - Alpha Teknova Inc | HOLD | 0 @ USD 5.2 | USD 0 | The current share valuation price of TKNO based on adjusted close was USD 5.2. The average price that TKNO shares were previous bought at was USD 7.95439. The current market price is -34.6% lower than average price they were purchased at. The value of the holding in TKNO has fallen by USD 7,901 compared to the previous valuation of Alpha Teknova Inc |
| TNGX - Tango Therapeutics Inc | HOLD | 0 @ 1.86 | 0 | |
| TRDA - Entrada Therapeutics Inc | HOLD | 0 @ 10.82 | 0 | |
| TRML - Tourmaline Bio Inc. | HOLD | 0 @ 17.04 | 0 | |
| TRVI - Trevi Therapeutics Inc | HOLD | 0 @ USD 6.29 | USD 0 | The current share valuation price of TRVI based on adjusted close was USD 6.29. The average price that TRVI shares were previous bought at was USD 3.95111. The current market price is 59.2% higher than average price they were purchased at. The value of the holding in TRVI has fallen by USD 380 compared to the previous valuation of Trevi Therapeutics Inc |
| TSHA - Taysha Gene Therapies Inc | HOLD | 0 @ 1.72 | 0 | |
| TSVT - 2Seventy Bio Inc | HOLD | 0 @ USD 4.94998 | USD 0 | The current share valuation price of TSVT based on adjusted close was USD 4.94998. The average price that TSVT shares were previous bought at was USD 2.48889. The current market price is 98.9% higher than average price they were purchased at. USD 0 compared to the previous valuation of 2Seventy Bio Inc however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| TVGN - Tevogen Bio Holdings Inc | HOLD | 0 @ USD 1.11 | USD 0 | The current share valuation price of TVGN based on adjusted close was USD 1.11. The average price that TVGN shares were previous bought at was USD 1.38132. The current market price is -19.6% lower than average price they were purchased at. USD 0 compared to the previous valuation of Tevogen Bio Holdings Inc however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| TVTX - Travere Therapeutics Inc | HOLD | 0 @ 19.13 | 0 | |
| TWST - Twist Bioscience Corp | HOLD | 0 @ 39.12 | 0 | |
| TXG - 10X Genomics Inc | HOLD | 0 @ 9.88001 | 0 | |
| TXG - Terex Corporation | HOLD | 0 @ 9.88001 | 0 | |
| TYRA - Tyra Biosciences Inc | HOLD | 0 @ USD 10.74 | USD 0 | The current share valuation price of TYRA based on adjusted close was USD 10.74. The average price that TYRA shares were previous bought at was USD 13.9145. The current market price is -22.8% lower than average price they were purchased at. The value of the holding in TYRA has fallen by USD 1,998 compared to the previous valuation of Tyra Biosciences Inc |
| URGN - UroGen Pharma Ltd | HOLD | 0 @ 10.9 | 0 | |
| UTHR - United Therapeutics Corporation | HOLD | 0 @ 305.39 | 0 | |
| VCEL - Vericel Corp Ord | HOLD | 0 @ 45.39 | 0 | |
| VCYT - Veracyte Inc | HOLD | 0 @ 30.43 | 0 | |
| VERA - Vera Therapeutics Inc | HOLD | 0 @ 27.66 | 0 | |
| VERV - Verve Therapeutics Inc | HOLD | 0 @ 6.15 | 0 | |
| VIR - Vir Biotechnology Inc | HOLD | 0 @ 7 | 0 | |
| VIR - Vidrala S.A | HOLD | 0 @ 7 | 0 | |
| VNDA - Vanda Pharmaceuticals Inc | HOLD | 0 @ 4.92 | 0 | |
| VRNA - Verona Pharma PLC ADR | HOLD | 0 @ 65.36 | 0 | |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ 502.92 | 0 | |
| VTRS - Viatris Inc | HOLD | 0 @ 8.98 | 0 | |
| VYGR - Voyager Therapeutics Inc | HOLD | 0 @ 4.06501 | 0 | |
| WVE - Wave Life Sciences Ltd | HOLD | 0 @ 10.27 | 0 | |
| XENE - Xenon Pharmaceuticals Inc | HOLD | 0 @ 35.18 | 0 | |
| XERS - Xeris Pharmaceuticals Inc | HOLD | 0 @ 4.56 | 0 | |
| XNCR - Xencor Inc | HOLD | 0 @ 12.87 | 0 | |
| YMAB - Y mAbs Therapeutics | HOLD | 0 @ 4.72998 | 0 | |
| ZLAB - Zai Lab Ltd | HOLD | 0 @ 36.14 | 0 | |
| ZVRA - Zevra Therapeutics Inc. | HOLD | 0 @ USD 7.94 | USD 0 | The current share valuation price of ZVRA based on adjusted close was USD 7.94. The average price that ZVRA shares were previous bought at was USD 7.805. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in ZVRA has increased by USD 527 compared to the previous valuation of Zevra Therapeutics Inc. however if the holding was sold on 2025-03-13 this would crystalise an overall loss. |
| ZYME - Zymeworks Inc. Common Stock | HOLD | 0 @ 12.55 | 0 | |